You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd.

BSE: 524663 Sector: Health care
NSE: N.A. ISIN Code: INE994B01014
BSE 00:00 | 10 Aug 26.25 0.05
(0.19%)
OPEN

26.40

HIGH

27.00

LOW

26.10

NSE 05:30 | 01 Jan Bharat Immunological & Biological Corporation Ltd
OPEN 26.40
PREVIOUS CLOSE 26.20
VOLUME 18531
52-Week high 63.20
52-Week low 22.80
P/E
Mkt Cap.(Rs cr) 113
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 26.40
CLOSE 26.20
VOLUME 18531
52-Week high 63.20
52-Week low 22.80
P/E
Mkt Cap.(Rs cr) 113
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Bharat Immunological & Biological Corporation Ltd. (BHARATIMMUNOLOG) - Director Report

Company director report

On behalf of the Board of Directors I hereby present the 32nd Annual Report togetherwith Audited Statements of Accountants of the Company for the year ended March 31 2021.

FINANCIAL RESULTS

During the year 2020-21 BIBCOL has turnover of Rs. 8533.36 Lakhs as against theprevious year turnover of Rs. 6683.65 lakhs. Total Comprehensive Income for the year isof Rs. 475.44 Lakhs as compared to the previous year Comprehensive income of Rs. -1020.36lakhs. Company is continued to deposit a part of sale of hand sanitizer in PrimeMinister's Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund). Inthe year 2020-21 Rs. 16406 has been deposited.

DIVIDEND

In view of the accumulated losses company has not been recommending any dividend forthe year.

FUTURE OUTLOOK

Company is in diversification mode and two projects namely Oral Cholera Vaccine andplasma derived medicines are under execution. Further the company is working for gettingsanction for Covaxin Project to augment the production of Covaxin in the country.

FIXED DEPOSIT

The company has not accepted/ invited any Deposits from public pursuant to Section 73of the Companies Act 2013 till the end of the year under review.

DIRECTORS

Dr. Sanjay Kumar Mishra has joined as Managing Director w.e.f. 17.09.2021. Sh. ChandraPrakash Goyal has been relieved as Managing Director of the company on 16.09.2021.

LISTING OF SECURITIES

The shares of the company are listed with Bombay Stock Exchange. The company has paidannual listing fee to Bombay Stock Exchange for the year 2021-2022. AUDITOR'S REPORT

M/s. Rasool Singhal & Co. Chartered Accountants has been appointed as StatutoryAuditors of the Company by Comptroller and Auditor General of India for the period underreview. Comments on the observation of the Auditors' / CAG are given as addendum toDirector's Report and are self-explanatory and/or suitably explained in various Notes onthe Accounts.

CONSERVATION OF ENERGY TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO

In accordance with the provisions of Sec.134 (3)(m) of the Companies Act2013 and theCompanies (Accounts) Rule 2014 the required information relating to conservation ofenergy technology absorption and foreign exchange outgo is available at Annexure andforms an integral part of this report.

DIRECTOR'S RESPONSIBILITY STATEMENT:

Based on the work performed by the Internal Statutory and Secretarial Auditorsincluding audit of internal financial controls over financial reporting by the StatutoryAuditors and reviews performed by the Management and the Audit Committee and subject tothe disclosures in the Annual Accounts and also on the basis of the discussion with theStatutory Auditors of the Company from time to time we state as under:

(a) in the preparation of the annual accounts the applicable accounting standards hadbeen followed along with proper explanation relating to material departures;

(b) the directors had selected such accounting policies and applied them consistentlyand made judgments and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the company at the end of the financial year and ofthe profit and loss of the company for that period;

(c) the directors had taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provisions of this Act for safeguarding theassets of the company and for preventing and detecting fraud and other irregularities;

(d) the directors had prepared the annual accounts on a going concern basis; and

(e) the directors had laid down internal financial controls to be followed by thecompany and that such internal financial controls are adequate and were operatingeffectively.

Since the Company is Government company and it is following the General Financial Rulesof Ministry of Finance Government of India. Further the Company has some Rules of its ownand in absence of any particular clarity; the Government of India prescribed Rules arebeing followed.

(f) the directors had devised proper systems to ensure compliance with the provisionsof all applicable laws and that such systems were adequate and operating effectively.

CORPORATE SOCIAL RESPONSIBILITY

The provision of section 135 of the Companies Act 2013 for Corporate SocialResponsibility was not applicable on the company for the Financial Year 2020-21.

The company has CSR Committee of its Directors comprising of Dr. Sudhanshu Vrati Dr.Mohd. Aslam and Sh. Roshan Lal.

PERSONNEL

The company has always considered its human resource as the most important resource.Emphasis was laid on competency building of employees for higher roles in the Company. Thecompany has trained its employees in-house training on various topics for capabilityenhancement and skill development. The topics for training were chosen to promote overalldevelopment and to foster understanding collaboration teamwork and leadership qualitiesamongst the employees in the organization.

CORPORATE GOVERNANCE

In terms of SEBI's (Listing Obligation and Disclosure Requirements) Regulations 2015 areport on Corporate Governance for the year ended 31st March 2021 supported by acertificate from the Practicing Company Secretary confirming compliance of conditionsforms part of this report.

SECRETARIAL AUDIT

In terms of Section 204(1) of the Companies Act 2013 the Board has appointed M/sAgrawal Manish Kumar & Co. Practicing Company Secretary as Secretarial Auditor forthe conducting secretarial compliance audit for the financial year ended 31st March 2021.Their Report has been annexed with this report and forms part of this Report.

COST AUDIT

Maintenance of cost records as specified by the Central Government under sub-section(1) of section 148 of the Companies Act 2013 is required by the Company and accordinglysuch accounts and records are made and maintained and the Audit Report has been filed atMCA for the year 2020-21. M/s Sunny Chhabra & Co. is the cost auditor of the company.

EXTRACT OF ANNUAL RETURN

Pursuant to section 92(3) of the Companies Act 2013 and rule 12(1) of the Companies(Management and Administration) Rules 2014 an extract of the Annual Report are given inthe annexure to this report.

DISCLOSURES AS PER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION PROHIBITIONAND REDRESSAL) ACT 2013

The company has complied with provisions relating to the constitution of InternalComplaints Committee under the Sexual Harassment of Women at Workplace (PreventionProhibition and Redressal) Act 2013. During the year under review no complaints receivedon sexual harassment.

ACKNOWLEDGEMENT

The Directors acknowledge with gratitude the co-operation extended by Department ofBiotechnology the administrative department various agencies of the Central GovernmentBank and all Business Associates during the year under review. The Board also takes thisopportunity to express its deep gratitude for the continuous support received from theShareholders and Whole hearted cooperation given by the employees of the Company workingat various levels.

Place: Bulandshahr For and on behalf of Board of Director
Date : 29.10.2021 Managing Director

.